Clinical Trial Update: Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the CALEC graft for limbal stem cell deficiency has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limbal Stem Cell Deficiency

Drugs mentioned

• CALEC graft (cultured autologous limbal epithelial cell graft)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Limbal Stem Cell Deficiency | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-01-15